REENA JAIN: Open Payments
NPI 1538171723 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,263 in 65 payments from 18 companies in 2025. Trend: 2023 $664 · 2024 $1,034 · 2025 $1,263
Food & beverage: $1,263
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $236 |
| GENZYME CORPORATION | 5 | $153 |
| Janssen Biotech, Inc. | 6 | $115 |
| Incyte Corporation | 1 | $113 |
| UCB, Inc. | 4 | $106 |
| Organon LLC | 10 | $98 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $71 |
| Regeneron Healthcare Solutions, Inc. | 3 | $71 |
| Amgen Inc. | 3 | $63 |
| Galderma Laboratories, L.P. | 2 | $37 |
Products named: DUPIXENT, RINVOQ, TREMFYA, OPZELURA, Bimzelx, VTAMA, SKYRIZI, LIBTAYO.
Industry payments across AZ — which companies pay providers there.
